• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (4)
    • Cholesterol reducer and thrombolytic therapy in acute ischemic stroke patients.
    • DNA Footprinting
    • Marine pharmacology in 1999: compounds with antibacterial, anticoagulant, antifungal, anthelmintic, anti-inflammatory, antiplatelet, antiprotozoal and antiviral activities affecting the cardiovascular, endocrine, immune and nervous systems, and other miscellaneous mechanisms of action.
    • Proton-Coupled Folate Transporter
    • See All 4 Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

Cholesterol reducer and thrombolytic therapy in acute ischemic stroke patients.

Cholesterol reducer and thrombolytic therapy in acute ischemic stroke patients. Lipids Health Dis. 2020 May 06; 19(1):84.

View in: PubMed

subject areas
  • Age Factors
  • Aged
  • Aged, 80 and over
  • Anticholesteremic Agents
  • Atrial Fibrillation
  • Combined Modality Therapy
  • Female
  • Fibrinolytic Agents
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Patient Admission
  • Recombinant Proteins
  • Retrospective Studies
  • Risk Factors
  • ROC Curve
  • Tissue Plasminogen Activator
  • Treatment Outcome

authors with profiles
  • Thomas Nathaniel